Oral regimen consisting of UFT/UZEL for elderly patients with colorectal cancer

Hepato-Gastroenterology

Volumn 53, Issue 68, 2006, Pages 209-212

  Tsutsumi, Soichi ^a   Yamaguchi, Satoru ^a   Tsuboi, Kaori ^a   Fukasawa, Takaharu ^a   Yamaki, Sayaka ^a   Asao, Takayuki ^a   Kuwano, Hiroyuki ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemotherapy; Colorectal cancer; Elder patients; UFT

Indexed keywords

FLUOROURACIL; FOLINATE CALCIUM; TEGAFUR; UFT;

ADULT; ADVANCED CANCER; AGED; AGING; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; CLINICAL ARTICLE; COLORECTAL CANCER; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ELDERLY CARE; FEMALE; HUMAN; MALE; NAUSEA; PRIORITY JOURNAL; SIDE EFFECT; SURVIVAL RATE;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LEUCOVORIN; MALE; SURVIVAL RATE; TEGAFUR; TREATMENT OUTCOME; URACIL; VITAMIN B COMPLEX;

EID: 33645638806     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, MPH, Ward E, Feuer EJ, Thun MJ: Cancer statistics 2004. CA Cancer J Clin 2004; 54:8-29.
2. Ajiki W, Tsukuma H, Oshima A: Research Group for Population-based Cancer Registration in Japan: Cancer incidence and incidence rates in Japan in 1999: estimates based on data from 11 population-based cancer registries. Jpn J Clin Oncol 2004; 34:352-356.
3. Gatta G, Ciccolallo L, Capocaccia R, Coleman MP, Hakulinen T, Moller H, Berrino F; EUROCARE Working Group: Differences in colorectal cancer survival between European and US populations: the importance of sub-site and morphology. Eur J Cancer 2003; 39:2214-2222.
4. Yancik R: Cancer burden in the aged: An epidemiologic and demographic overview. Cancer 1997; 80:1273-1283.
5. Petrioli R, Lorenzi M, Aquino A. Marsili S, Frediani B, Palazzuoli V, Marzocca G, Botta G, Tani F, De Martine A, et al: Treatment of advanced colorectal cancer with high-dose intensity folinic acid and 5-fluorouracil plus supportive care. Eur J Cancer 1995; 31A:2105-2108.
6. Ho DH, Pazdur R, Covington W, Brown N, Huo YY, Lassere Y, Kuritani J: Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5- fluorouracil. Clin Cancer Res 1998; 4:2085-2088.
7. Cao S, Frank C, Shirasaka T, Rustum YM: 5-Fluorouracil prodrug: Role of anabolic and catabolic pathway modulation in therapy of colorectal cancer. Clin Cancer Res 1995; 1:839-845.
8. Douillard JY, Hoff PM, Skillings JR, et al: Multicenter phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 2002; 20:3605-3616.
9. Fukuoka M, Yano S, Giaccone G, Tamura T, Nakagawa K, Douillard JY, Nishiwaki Y, Vansteenkiste J, Kudoh S, Rischin D, Eek R, Horai T, Noda K, Takata I, Smit E, Averbuch S, Macleod A, Feyereislova A, Dong RP, Baselga J: Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer J Clin Oncol 2003; 21:2237-2246.
10. World Health Organization: Handbook for reporting results of cancer treatment (offset publication no. 48). WHO, Geneva, 1979.
11. National Cancer Institute Common Toxicity Criteria.
12. Sakamoto J, Ohashi Y, Hamada C, Buyse M, Burzykowski T, Piedbois P; Meta-Analysis Group of the Japanese Society for Cancer of the Colon and Rectum; Meta-Analysis Group in Cancer: Efficacy of oral adjuvant therapy after resection of colorectal cancer: 5-year results from three randomized trials. J Clin Oncol 2004; 22(3):484-492.
13. Verso M, Agnelli G: Venous thromboembolism associated with long-term use of central venous catheters in cancer patients. J Clin Oncol 2003; 21:3665-3675.
14. de Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J, Boni C, Cortes-Funes H, Cervantes A, Freyer G, Papamichael D, Le Bail N, Louvet C, Hendler D, de Braud F, Wilson C, Morvan F, Bonetti A: Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2000; 18:2938-2947.